Oxford Events, the new replacement for OxTalks, will launch on 16th March. The two-week OxTalks freeze period starts on Monday 2nd March. During this time, there will be no facility to publish or edit events. The existing OxTalks site will remain available to view during this period. Once Oxford Events launches, you will need a Halo login to submit events. Full details are available on the Staff Gateway.
Kevin Blyth is Professor of Respiratory Medicine in the School of Cancer Sciences at the University of Glasgow. He splits his time between the Wolfson Wohl Cancer Research Centre, the CRUK Scotland Institute and the Queen Elizabeth University Hospital (QEUH), where he leads the Glasgow Pleural Disease Unit, a multidisciplinary team delivering all aspects of pleural medicine, including thoracoscopy and clinical trials. He founded the Macmillan Scottish Mesothelioma Network, which coordinates care and access to clinical trials for patients across Scotland and is National Clinical Lead for Mesothelioma.
He leads a translational research program focused on mesothelioma and is Chief Investigator of the PREDICT-Meso International Accelerator Network, which currently comprises >140 investigators from 90 institutions across 16 countries. He is recent ex-Chair of ERS Pleural Assembly, a member of the IASLC Mesothelioma Committee, a Trustee of Mesothelioma UK and an Associate Editor of Thorax.
